Geneos Wealth Management Inc. Spectrum Pharmaceuticals Inc Transaction History

Geneos Wealth Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Sep 07, 2021	SELL	$9.08 - $11.84 $1,234 - $1,610	-136 Closed	0 $0
Q3 2018 Sep 07, 2021	BUY	$16.52 - $24.82 $2,246 - $3,375	136 New	136 $2,000
Q2 2018 Sep 07, 2021	SELL	$14.31 - $21.75 $1,946 - $2,958	-136 Closed	0 $0
Q4 2017 Sep 07, 2021	SELL	$13.36 - $20.73 $27,788 - $43,118	-2,080 Reduced 93.86%	136 $2,000
Q1 2017 Sep 07, 2021	SELL	N/A	-20 Reduced 0.89%	2,216 $14,000
Q1 2016 Sep 07, 2021	BUY	N/A	2,236	2,236 $14,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.